Clinical Trial Update: Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pentoxifylline as an anti-inflammatory treatment for rheumatoid arthritis. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis | Phase 2 | Status: RECRUITING